Evaluating CPS in Lymph Node Specimens: Part I

Join Agilent CDx Pathologist, Dr. Kristopher Kersch, as he walks through an Esophageal Cancer case stained with PD-L1 IHC 22C3 pharmDx featuring a lymph node with metastatic tumor. This video helps clarify approaches for evaluating PD-L1 staining Mononuclear Inflammatory Cells (MICs) in lymph nodes containing metastatic tumor deposits.​

The Spotlight Video Series walks you through Combined Positive Score (CPS) principles and scoring strategies for cases stained with PD-L1 IHC 22C3 pharmDx. Through this engaging series, Agilent PD-L1 experts will help you to confidently:​

• Evaluate H&E, NCR, and PD-L1 slides for adequacy ​
• Understand inclusion/exclusion criteria and other core principles of Combined Positive Score (CPS)​
• Determine the best approaches for scoring cases based on specific characteristics and features​
• Navigate challenging morphology and staining characteristics​

This website addresses general principles for CDx scoring and is for education purposes only. Not all cancer indications mentioned are approved worldwide. Please refer to local Instructions for Use for further details.​D0113771_1.00